(Isotretinoin) News, Updated Regularly

Drugs & Medications - Accutane Oral - WebMD
September 30, 2008, 11:47 am

Women who are pregnant must not use isotretinoin. Women must avoid becoming pregnant while taking this medication. Serious (sometimes fatal) birth defects, miscarriages, and premature births have occurred when this drug has been used during pregnancy ...

Go To Next Page>> - Tiscali
October 1, 2008, 2:02 pm

The side effects listed above may not include all of the side effects reported by the drug's manufacturer. For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or ...

The Complete Book of Men's Health - Part 2: Illness and Disease - Tiscali
August 14, 2008, 4:15 am

Acne is a common inflammatory skin disease due to infections of blocked hair follicles. Each hair follicle is associated with a sebaceous gland which secretes a conditioning oil (sebum) into the follicle. This normally travels along the pilosebaceous ...

FDA Advisors Revise Limits on Acne Drug Accutane That Leads to ... - LifeNews.com
July 24, 2008, 5:18 pm

Washington, DC (LifeNews.com) -- Food and Drug Administration advisors on Wednesday urged the federal health agency to place fewer restrictions on the acne drug Accutane and generic versions of it. The drug has caused significant problems, such as ...

Cipher reports third quarter fiscal 2008 results - CNW Group
November 6, 2008, 3:54 pm

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 7 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2008. Q3 2008 Summary ...

How is acne treated? - Health 24
August 16, 2008, 5:38 am

No treatment is needed for the occasional pimple or two, but if acne causes you distress, something should be done about it. Many different treatments are available, but not each is appropriate for everyone. It is therefore important to keep ...

Cipher Pharmaceuticals to present at Rodman & Renshaw Healthcare ... - CNW Group
November 5, 2008, 4:24 pm

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 5 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, will present a corporate update at Rodman & Renshaw's ...

Drugs & Medications - Methotrexate (Anti-Rheumatic) Oral - WebMD
September 30, 2008, 10:00 am

Methotrexate has rarely caused serious (sometimes fatal) side effects. Therefore, this medication should be used only to treat cancer or severe diseases caused by an overactive immune system (e.g., psoriasis, rheumatoid arthritis). Methotrexate has ...

ESAs Should Continue to be Used for Anemia in Cancer Patients, Says ... - Medscape News
August 16, 2008, 6:00 am

Read the latest news on this topic here . March 14, 2008 ? Erythropoiesis-stimulating agents (ESAs) should continue to be used for chemotherapy-induced anemia: this was the main conclusion from yesterday's meeting of the US Food and Drug ...

Rodman & Renshaw Annual Global Investment Conference Presenter ... - TMCnet
November 11, 2008, 3:55 pm

NEW YORK --(Business Wire)-- The Rodman & Renshaw Annual Global Investment Conference takes place November 10, 2008 - November 12, 2008 at the New York Palace Hotel in New York. Listed below are the Rodman & Renshaw Annual Global Investment ...

Are you looking for additional Isotretinoin () news? Try our new " News Focus" area.

Are you looking for additional Isotretinoin () information? Try our new " Related Blog Entries" area.

Off-site (Isotretinoin) Links, User Submitted

The following links have been collected through user bookmark submission in the _Isotretinoin category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Off-site Research Links

If you still need additional information on then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.